Follow
Carsten Magnus
Carsten Magnus
F. Hoffmann-La Roche
Verified email at roche.com - Homepage
Title
Cited by
Cited by
Year
Determinants of HIV-1 broadly neutralizing antibody induction
P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz, M Huber, DL Braun, ...
Nature medicine 22 (11), 1260-1267, 2016
1762016
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
P Rusert, A Krarup, C Magnus, OF Brandenberg, J Weber, AK Ehlert, ...
Journal of Experimental Medicine 208 (7), 1419-1433, 2011
1202011
Estimating the stoichiometry of human immunodeficiency virus entry
C Magnus, P Rusert, S Bonhoeffer, A Trkola, RR Regoes
Journal of virology 83 (3), 1523-1531, 2009
1172009
Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry
OF Brandenberg, C Magnus, P Rusert, RR Regoes, A Trkola
PLoS pathogens 11 (1), e1004595, 2015
1112015
Taming the BEAST—A community teaching material resource for BEAST 2
J Barido-Sottani, V Bošková, LD Plessis, D Kühnert, C Magnus, V Mitov, ...
Systematic biology 67 (1), 170-174, 2018
1042018
Myc boxes, which are conserved in Myc family proteins, are signals for protein degradation via the proteasome
EM Flinn, CMC Busch, APH Wright
Molecular and cellular biology 18 (10), 5961-5969, 1998
1021998
Modelling the course of an HIV infection: insights from ecology and evolution
S Alizon, C Magnus
Viruses 4 (10), 1984-2013, 2012
1002012
Capacity of broadly neutralizing antibodies to inhibit HIV-1 cell-cell transmission is strain-and epitope-dependent
L Reh, C Magnus, M Schanz, J Weber, T Uhr, P Rusert, A Trkola
PLoS pathogens 11 (7), e1004966, 2015
902015
Classic reaction kinetics can explain complex patterns of antibiotic action
P Abel zur Wiesch, S Abel, S Gkotzis, P Ocampo, J Engelstädter, ...
Science Translational Medicine 7 (287), 287ra73, 2015
842015
The HIV-1 entry process: a stoichiometric view
OF Brandenberg, C Magnus, RR Regoes, A Trkola
Trends in microbiology 23 (12), 763-774, 2015
622015
Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs
CS Oberle, B Joos, P Rusert, NK Campbell, D Beauparlant, H Kuster, ...
Retrovirology 13, 1-20, 2016
602016
Estimating the stoichiometry of HIV neutralization
C Magnus, RR Regoes
PLoS computational biology 6 (3), e1000713, 2010
392010
Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptation
P Domingues, D Eletto, C Magnus, HL Turkington, S Schmutz, O Zagordi, ...
Nature communications 10 (1), 3396, 2019
362019
The influence of phylodynamic model specifications on parameter estimates of the Zika virus epidemic
V Boskova, T Stadler, C Magnus
Virus evolution 4 (1), vex044, 2018
312018
Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality
D Beauparlant, P Rusert, C Magnus, C Kadelka, J Weber, T Uhr, ...
PLoS pathogens 13 (3), e1006255, 2017
302017
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters
OF Brandenberg, C Magnus, P Rusert, HF Günthard, RR Regoes, ...
PLoS Pathogens 13 (5), e1006313, 2017
292017
Restricted occupancy models for neutralization of HIV virions and populations
C Magnus, RR Regoes
Journal of Theoretical Biology 283 (1), 192-202, 2011
262011
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain’s exceptional capacity for sequence variation
OF Brandenberg, P Rusert, C Magnus, J Weber, J Böni, HF Günthard, ...
Retrovirology 11, 1-22, 2014
232014
Analysis of the subunit stoichiometries in viral entry
C Magnus, RR Regoes
PLoS One 7 (3), e33441, 2012
182012
Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack
WV Bonilla, N Kirchhammer, AF Marx, SM Kallert, MA Krzyzaniak, M Lu, ...
Cell Reports Medicine 2 (3), 2021
172021
The system can't perform the operation now. Try again later.
Articles 1–20